Abstract

This contract is designed to evaluate the activity and toxicity of Suramin in patients with AIDS and AIDS-related illnesses, including non-Hodgkin's lymphoma. Patients will receive Suramin for a period of one year and a number of parameters will be monitored including virology, pharmacokinetics, immune status and clinical response.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI062511-000
Application #
3595050
Study Section
Project Start
1985-12-06
Project End
Budget Start
1985-12-06
Budget End
1986-12-05
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost

  Institution

Name
University of Texas MD Anderson Cancer Center
Department
Type
Hospitals
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030